InMed Pharmaceuticals Inc. Common Shares

INMNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
1.43 USD
↘ 0.03 (2.05%)AT CLOSE (11:59 AM EDT)
1.46
↗ 0.03 (1.75%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
1.46
↗ 0.03 (1.75%)
🔴Market: CLOSED

InMed Pharmaceuticals Inc. Common Shares (INM) is currently trading at $1.45. Our models show a "Neutral" technical signal alongside a "Sell" fundamental rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Aug 24, 2026.

Open?$1.48
High?$1.61
Low?$1.41
Prev. Close?$1.46
Volume?164.4K
Avg. Volume?1.9M
VWAP?$1.49
Rel. Volume?0.09x
Bid / Ask
Bid?$1.24 × 100
Ask?$1.67 × 100
Spread?$0.43
Midpoint?$1.46
Valuation & Ratios
Market Cap?7.8M
Shares Out?3.3M
Float?3.0M
Float %?89.3%
P/E Ratio?N/A
P/B Ratio?1.13
EPS?-$1.59
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsCannabis›CBD & Hemp Products
Employees
13
Market Cap
7.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.inmedpharma.com
Listed
2020-11-10
Address
1445-885 WEST GEORGIA ST.
VANCOUVER, A1 V6C 3E8
Phone: (604) 669-7207
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
13
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?-18.93Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?2.81%Low
Short Interest?83.1K
Days to Cover?1.0
Free Float3.0M
Avg Daily Volume4.4M
Settlement Date2026-07-31
Financial Health
Current Ratio?4.92Strong
Quick Ratio?4.92Strong
Cash Ratio?3.68Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
94
1.13CHEAP▾
P/S?
Peers
100
S&P
59
2.40CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.3CHEAP▾
EV/Sales?
Peers
100
S&P
94
0.81CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-123.5%WEAK▾
ROA?
S&P
3
-93.2%WEAK▾
Cash Flow & Enterprise
FCF?$-7457501
Enterprise Value?$2.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist